Neulasta and Gentamicin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neulasta (pegfilgrastim) and Gentamicin (gentamicin sulfate). Common drug interactions include pulmonary embolism among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Neulasta and Gentamicin. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.



On Aug, 07, 2026

55 people who take Neulasta and Gentamicin together, and have interactions are studied.

Neulasta and Gentamicin drug interactions.

What are the common drug interactions of Neulasta and Gentamicin, by gender? *:

female:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)
  3. Vomiting
  4. Nausea (feeling of having an urge to vomit)
  5. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  6. Drug eruption (adverse drug reaction of the skin)
  7. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  8. Pain
  9. Skin infection
  10. Acute lymphocytic leukaemia (cancer of the white blood cells)

male:

  1. Fatigue (feeling of tiredness)
  2. Pyrexia (fever)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Lung disorder (lung disease)
  5. Respiratory distress (difficulty in breathing)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Asthenia (weakness)
  10. Chills (felling of cold)

What are the common drug interactions of Neulasta and Gentamicin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Injury
  3. Pain

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Skin infection
  2. Axillary mass
  3. Pain
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Rash
  6. Renal tubular disorder (disease of kidney tubules)
  7. Pyrexia (fever)
  8. Hyperchloraemia (an excess of chlorides in the blood)
  9. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  10. Hypokalaemia (low potassium)

60+:

  1. Fatigue (feeling of tiredness)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Drug eruption (adverse drug reaction of the skin)
  6. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  7. Rash erythematous (redness of the skin)
  8. Rash pustular (redness with pustules)
  9. Rash vesicular (rash with a small bubble)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 24 people, 43.64%
  2. Pain: 17 people, 30.91%
  3. Hypokalemia (low potassium): 15 people, 27.27%
  4. Constipation: 14 people, 25.45%
  5. Fungal Infection: 10 people, 18.18%
  6. Nasal Dryness (dry nose): 10 people, 18.18%
  7. Vulvovaginal Candidiasis (vulvovaginal infection by fungi): 10 people, 18.18%
  8. Oral Herpes (viral infection of mouth): 10 people, 18.18%
  9. Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 18.18%
  10. High Blood Pressure: 8 people, 14.55%

* Approximation only. Some reports may have incomplete information.

Do you take Neulasta and Gentamicin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neulasta and Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neulasta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neulasta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pegfilgrastim and gentamicin sulfate (the active ingredients of Neulasta and Gentamicin, respectively), and Neulasta and Gentamicin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: